Clinical trials · Spokane, WA
Myelodysplastic Syndromes clinical trials in Spokane
We’re tracking 3 recruiting myelodysplastic syndromes studies with a site in or near Spokane — including Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Spokane
- NCT04726241RecruitingPhase 1/Phase 2
Testing blood and bone marrow samples in young leukemia patients
This trial looks at blood and bone marrow samples from children and teens whose leukemia has come back or is hard to treat. The goal is to better understand the disease and guide future options for these patients.
Spokane, WashingtonAges Up to 22 years - NCT06577441RecruitingPhase 2
Adding enasidenib to usual care for higher-risk MDS with IDH2 mutation
This trial tests whether adding enasidenib (a targeted pill) to the standard chemotherapy (cedazuridine-decitabine) works better than the chemotherapy alone for people with higher-risk myelodysplastic syndrome (MDS) whose cells have a specific change in the IDH2 gene.
Post Falls, IdahoAges 18 years+ - NCT05564390RecruitingPhase 2
MyeloMATCH screening to match you to AML or MDS treatment
This study screens people with newly suspected acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) to see which treatment approach fits best—either a specific study treatment or standard care. It may help by directing you to the right option and by sharing your blood/bone marrow samples for research.
Post Falls, IdahoAges 18 years+
Hear when a new Myelodysplastic Syndromes trial opens near Spokane, WA
We’ll email you when one opens near Spokane, WA — at most once a week, no account needed, unsubscribe anytime.
Myelodysplastic Syndromes trials in other cities
Where these studies are running near Spokane
Institutions with a site for the recruiting myelodysplastic syndromes studies listed above.
- Kootenai Clinic Cancer Services - Post Falls · 2 studies
- Kootenai Health - Coeur d'Alene · 2 studies
- Providence Sacred Heart Medical Center and Children's Hospital
What taking part in a myelodysplastic syndromes study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting myelodysplastic syndromes studies in Washington.
Common questions
- Are there myelodysplastic syndromes clinical trials near Spokane?
- Yes. We're currently tracking 3 recruiting myelodysplastic syndromes studies with a site near Spokane, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a myelodysplastic syndromes study near Spokane?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Spokane to take part?
- Not necessarily. These studies have a site near Spokane, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a myelodysplastic syndromes trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New myelodysplastic syndromes studies open near Spokane regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.